Skip to content

Effects of Dextrose on Knee Osteoarthritis

Additional Therapeutic Effects of Dextrose to Hyaluronic Acid on Knee Osteoarthritis: a Double Blind, Randomized-controlled Clinical Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03238183
Enrollment
106
Registered
2017-08-03
Start date
2017-08-31
Completion date
2019-07-31
Last updated
2017-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Disturbance, Physical Activity

Keywords

knee osteoarthritis, hyaluronic acid, dextrose, therapeutic effects

Brief summary

Using double blind, randomized controlled design to study the immediate, short-term and intermediate-term therapeutic effects of ultrasound guided hyaluronic acid injection and hyaluronic acid combined dextrose injection to patients with knee osteoarthritis.

Detailed description

A total of 106 patients will be collected. The participants will be randomized into two groups, including hyaluronic acid group and hyaluronic acid combined dextrose group. The hyaluronic acid group will receive 3 times of hyaluronic acid injection per week in three weeks; the hyaluronic acid combined dextrose group will receive 3 times of hyaluronic acid combined dextrose injection per week in three weeks. The pain, physical activity, and functional performance will be evaluated. All the evaluations will be re-evaluated at one week after injection, one month after injection, three months after injection, and six month after injection. Subjects and the evaluator will be both blinded to the group's classification during the whole course of study.

Interventions

DRUGdextrose

compare the therapeutic effects of hyaluronic acid combined dextrose injections with hyaluronic acid injections only to patients with knee osteoarthritis

DEVICEhyaluronic acid

compare the therapeutic effects of hyaluronic acid combined dextrose injections with hyaluronic acid injections only to patients with knee osteoarthritis

Sponsors

Taipei Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* knee osteoarthritis with Kellgren/Lawrence grade II or III

Exclusion criteria

* who have neurological deficit, such as stroke who have implant in knee

Design outcomes

Primary

MeasureTime frameDescription
physical activity-on level walking timechanges from baseline to at one week after injection, one month after injection, three months after injection, and six month after injection10 meter walking
physical activity-stair climbing timechanges from baseline to at one week after injection, one month after injection, three months after injection, and six month after injectionstairs climbing
physical activity-chair rising timechanges from baseline to at one week after injection, one month after injection, three months after injection, and six month after injectionchair rising

Secondary

MeasureTime frameDescription
functional performancechanges from baseline to at one week after injection, one month after injection, three months after injection, and six month after injectionWestern Ontario and McMaster Universities Osteoarthritis index
quality of lifechanges from baseline to at one week after injection, one month after injection, three months after injection, and six month after injectionKnee Injury and Osteoarthritis Outcome Score

Countries

Taiwan

Contacts

Primary ContactRu-Lan Hsieh
M001052@ms.skh.org.tw228332211
Backup ContactRu-Lan Hsieh
rulan@tmu.edu.tw228332211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026